What's new
Fantasy Football - Footballguys Forums

This is a sample guest message. Register a free account today to become a member! Once signed in, you'll be able to participate on this site by adding your own topics and posts, as well as connect with other members through your own private inbox!

***OFFICIAL CYDY/Leronlimab Thread*** (8 Viewers)

So is the projection that the next level will be at or around $3.85 manana?
No.  I have no clue what tomorrow will bring.  $3.85 is just the next lower level of support.  

The material events will determine this thing - either good or bad.  

I asked what kind of chart someone is looking at to determine $CYDY is in Free Fall.  Because unless you are looking at something on an extremely short term time frame (like 1 or 5 min chart) it's not in Free Fall at all.  Price is just naturally testing levels of support.  And again if you just showed me this chart with no text to it...I'd say from a chartist point of view it's a BUY.

 
Last edited by a moderator:
No.  I have no clue what tomorrow will bring.  $3.85 is just the next lower level of support.  

The material events will determine this thing - either good or bad.  

I asked what kind of chart someone is looking at to determine $CYDY is in Free Fall.  Because unless you are looking at something on an extremely short term time frame (like 1 or 5 min chart) it's not in Free Fall at all.  Price is just naturally testing levels of support.  And again if you just showed me this chart with no text to it...I'd say from a chartist point of view it's a BUY.
Got it.  Thanks!

 
No.  I have no clue what tomorrow will bring.  $3.85 is just the next lower level of support.  

The material events will determine this thing - either good or bad.  

I asked what kind of chart someone is looking at to determine $CYDY is in Free Fall.  Because unless you are looking at something on an extremely short term time frame (like 1 or 5 min chart) it's not in Free Fall at all.  Price is just naturally testing levels of support.  And again if you just showed me this chart with no text to it...I'd say from a chartist point of view it's a BUY.
So that lower level of support is determined, per your chart, by looking back and doing exponential averaging over a year, correct? 

What's the thinking behind that as being an accurate indication of a lower level of support?  

 
So that lower level of support is determined, per your chart, by looking back and doing exponential averaging over a year, correct? 

What's the thinking behind that as being an accurate indication of a lower level of support?  
He's always right would be my answer.

 
I don't believe there will be.  Has NP mentioned that there would be?  Or are people just speculating that there might be?
It's just speculation.  Or hope.  It's hard imagining tomorrow's conference call being good if Nader tries to give verbal highlights of the M2M trial results.

 
CytoDyn Completes Non-dilutive $28.5 Million Convertible Note Financing with Conversion Rate at $10.00 Per Share without Warrants

https://www.cytodyn.com/newsroom/press-releases/detail/455/cytodyn-completes-non-dilutive-28-5-million-convertible

VANCOUVER, Washington, July 29, 2020 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company"), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today it completed a new non-dilutive convertible debt offering with an institutional investor, which provides $25 million of immediately available capital. The note, has a two-year maturity, bears interest at the rate of 10% per annum and is secured by all assets of the Company, excluding its intellectual property.  The note may be converted at the option of the investor into shares of the Company’s common stock at a conversion price of $10.00 per share.

Nader Pourhassan, Ph.D., President and Chief Executive Officer of CytoDyn, stated, “We are very pleased with the continued support and tremendous confidence demonstrated by this institution’s fourth financing round with us. They clearly understand the opportunity before us and we now have the liquidity to accelerate our business plan without tapping into the increased share authorization recently approved by our stockholders. This injection of capital will help us deliver leronlimab to patients as soon as the regulatory pathway is clear for potentially COVID-19 (for three different populations), Cancer (23 different indications), and HIV (combination, monotherapy, HIV cure and PrEP). I am very excited to share with all of our stakeholders the excitement we have around our COVID-19 therapies during tomorrow’s conference call, as well as our expected timelines.”  

 
He's always right would be my answer.
Ha.  I'll forward that to my family and friends.

Ok.  The chart posted is a simple chart.  One that is straight forward and easy(er) to understand.  My own charts are complicated.  If I were to post a picture of them it would be like asking you to understand the Chinese interpretation of ancient Babylonian hieroglyphics.  So it's dumbed down.

A very simple way to understand trend is through Moving Averages.  It is basic...but gives a good foundation on where price stands in the moment.  Is $XYZ Bullish?  Is XYZ Bearish?  Ideally one would purchase $XYZ at the VERY beginning of a new Bullish Trend.  One would then add to the position as long as the MA Lines remained in a Bullish position...adding when price tested those lines which act as support.

In the case of the $CYDY chart posted - Trend turned Bullish in Dec 2019.  And Price tagged the lower support in Feb, March and July.  Since the trend remained Bullish - those would have presented excellent opportunities to add to or open a position.  Sometimes that can be uncomfortable.

You might ask why 34/89 MA?  Most are familiar with the 50/200 MA identification of a trend.  34/89, I have found is faster and more accurate.  There is no magic to it - just what I prefer and seems to hold no matter what the underlying stock happens to be.  I want to be early in to a bull trend and early out when it flips.  Feel free to test with you own positions - I'd be surprised if it doesn't perform.

Often peopled get FOMO'd.  They watched $CYDY go from $.30 to $10 and finally saw a chance when it dropped from there.  Maybe they opened their position at $6.50 in early July, and have seen scare opportunity for any gain.  When price explodes away from MA support - it is more common than not for it to come back and test (or for price to drift while the MA lines catch up), and the further from support it gets the harsher the move down is.  $CYDY over the past month is a textbook example of a bull trend rocket from a charting perspective.  But again - you read this board or Yahoo and it's easy to get scared out.  What's your goal here - because you can't hit a home run if you are scared of the next pitch.

Now understand. The future price imo is very difficult to predict.  In general - the odds would favor up -based off how this chart looks...but good news doesn't necessarily mean tomorrow's "news".

The OTC and small biotech companies are more miss than hit.  I've experienced great news where the stock tanked.  Anything can happen - and we should all be prepared for the very worst even if the news is good. Because the material event will have a huge impact on future price right now the technicals are less important - not irrelevant but not critical to providing the best road map for future price direction.

I'm a big believer in taking a small portion of your portfolio and trying to hit HRs and Grand Slams (like 10% of your portfolio spread across 5 different positions).  To me it's fun.  I enjoy the stress of it too.  But it's not for everyone or even most.  I think if a person wanted to take their profits - they should and not think 2x about it.  Each day and every trade is a new opportunity to learn something.  And $CYDY will certainly be one of those we will all look back on and say - DAMN - one way or the other.  Good luck to all of us.

 
PR says they are very excited to share the excitement about the therapies but the "expected timelines" sounds like we will likely be getting just a peek.

T

 
Essentially their Lender feels that $10 future value for the stock is a deal and is willing to bet $25 million on it

 
It looks like they were able to raise capital without diluting the shares.  That is good.  If they were to issue more shares to raise capital then the share price would drop accordingly.  I imagine we could see a small increase on the share price tomorrow as share dilution was likely mostly priced in.
It can potentially dilute at $10/share.  It would be a good problem to have.

 
Nobody is signing over 25M without seeing some data. RIP to all the panic sellers today. 
a new non-dilutive convertible debt offering with an institutional investor, which provides $25 million of immediately available capital. The note, has a two-year maturity, bears interest at the rate of 10% per annum and is secured by all assets of the Company, excluding its intellectual property.
Better yet, it's secured by all assets of a 10 person company likely operating out of a space smaller than your house and doesn't included the freaking intellectual property.  I have more assets in my garage who my car is parked in the street than this company.  

Either NP has the goods or he makes Bernie Madoff look like a kindergarten con-artist.

 
Better yet, it's secured by all assets of a 10 person company likely operating out of a space smaller than your house and doesn't included the freaking intellectual property.  I have more assets in my garage who my car is parked in the street than this company.  

Either NP has the goods or he makes Bernie Madoff look like a kindergarten con-artist.
And probably gives CYDY enough $$$ to meet the operating cash requirement to uplist.  This financing is a very big positive IMO.

 
PR says they are very excited to share the excitement about the therapies but the "expected timelines" sounds like we will likely be getting just a peek.

T
Yah, first this is classic Nader:  "I am very excited to share with all of our stakeholders the excitement we have around our COVID-19 therapies during tomorrow’s conference call, as well as our expected timelines.”

Second, this to me confirms we hear nothing of substance tomorrow on the trials.

 
Better yet, it's secured by all assets of a 10 person company likely operating out of a space smaller than your house and doesn't included the freaking intellectual property.  I have more assets in my garage who my car is parked in the street than this company.  

Either NP has the goods or he makes Bernie Madoff look like a kindergarten con-artist.
Hey you are funny and not like a clown.

Its good to have some good news and added hope after the last few days.

 
one of my little stocklings diluted today for about 65% of the listed share price.

those 52 million shares went in the first twenty minutes of trading.  Volume ended up being over 100 million shares.

It crept back up about 10 percent after the dilution.

 
I don't believe there will be.  Has NP mentioned that there would be?  Or are people just speculating that there might be?
100% speculation which is odd since they’ve announced the conference call to start after hours. I would be shocked to see any trial results before the call. 

 
It looks like they were able to raise capital without diluting the shares.  That is good.  If they were to issue more shares to raise capital then the share price would drop accordingly.  I imagine we could see a small increase on the share price tomorrow as share dilution was likely mostly priced in.
That’s how I read it too but just wanted to make sure as I’m outta my depth in this field.  Thanks

 
The note is a 2 year note at 10% interest.  It's backed by the assets of the company.  Uplisting required a certain amount of assets, so I wouldn't be surprised if they had sufficient assets on hand to secure the loan.  Is a 10% interest loan on 25 million payable in 2 years excellent terms if it's secured by significant assets?  Legit question.

 
The note is a 2 year note at 10% interest.  It's backed by the assets of the company.  Uplisting required a certain amount of assets, so I wouldn't be surprised if they had sufficient assets on hand to secure the loan.  Is a 10% interest loan on 25 million payable in 2 years excellent terms if it's secured by significant assets?  Legit question.
The last financial statement shows $29,000 in property, plant, and equipment (basically less than what's in my garage) and $14.5 million in intangible assets.  This loan isn't secured by jackchet.

 

Users who are viewing this thread

Back
Top